{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:41:20Z","timestamp":1792680080119,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-026-05837-y","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:38:08Z","timestamp":1792672688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An interpretable contrast-enhanced CT-based cross-attention transformer model for predicting progression-free survival in muscle-invasive bladder cancer: a multicenter study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1263-9487","authenticated-orcid":false,"given":"Yuanyuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaixian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8313-7632","authenticated-orcid":false,"given":"Hexiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"issue":"3","key":"5837_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 74(3):229\u201363","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"1","key":"5837_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J et al (2023) Bladder cancer. Nature Reviews Disease Primers 9(1):58","journal-title":"Nature Reviews Disease Primers"},{"issue":"5","key":"5837_CR3","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.eururo.2025.02.019","volume":"87","author":"AG van der Heijden","year":"2025","unstructured":"van der Heijden AG, Bruins HM, Carrion A, Cathomas R, Comp\u00e9rat E, Dimitropoulos K et al (2025) European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines. European Urology 87(5):582\u2013600","journal-title":"European Urology"},{"key":"5837_CR4","first-page":"e076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L. Advances in diagnosis and treatment of bladder cancer. BMJ (Clinical research ed). 2024;384:e076743.","journal-title":"BMJ (Clinical research ed)"},{"issue":"3","key":"5837_CR5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","volume":"71","author":"J Alfred Witjes","year":"2017","unstructured":"Alfred Witjes J, Lebret T, Comp\u00e9rat EM, Cowan NC, De Santis M, Bruins HM et al (2017) Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. European Urology 71(3):462\u201375","journal-title":"European Urology"},{"issue":"8","key":"5837_CR6","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nrurol.2016.114","volume":"13","author":"SP Lerner","year":"2016","unstructured":"Lerner SP (2016) Bladder cancer: ASCO endorses EAU muscle-invasive bladder cancer guidelines. Nature Reviews Urology 13(8):440\u20131","journal-title":"Nature Reviews Urology"},{"issue":"3","key":"5837_CR7","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. European Urology 49(3):466\u20135 (discussion 75\u2009\u2013\u20097)","journal-title":"European Urology"},{"issue":"1","key":"5837_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","volume":"69","author":"S Cambier","year":"2016","unstructured":"Cambier S, Sylvester RJ, Collette L, Gontero P, Brausi MA, van Andel G et al (2016) EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1\u20133 Years of Maintenance Bacillus Calmette-Gu\u00e9rin. European Urology 69(1):60\u20139","journal-title":"European Urology"},{"issue":"5","key":"5837_CR9","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","volume":"182","author":"J Fernandez-Gomez","year":"2009","unstructured":"Fernandez-Gomez J, Madero R, Solsona E, Unda M, Martinez-Pi\u00f1eiro L, Gonzalez M et al (2009) Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model. The Journal of Urology 182(5):2195\u2013203","journal-title":"The Journal of Urology"},{"issue":"4 Pt 1","key":"5837_CR10","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.juro.2006.06.025","volume":"176","author":"PI Karakiewicz","year":"2006","unstructured":"Karakiewicz PI, Shariat SF, Palapattu GS, Gilad AE, Lotan Y, Rogers CG et al (2006) Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. The Journal of Urology 176(4 Pt 1):1354\u201361 (discussion 61\u2009\u2013\u20092)","journal-title":"The Journal of Urology"},{"issue":"24","key":"5837_CR11","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1200\/JCO.2005.05.3884","volume":"24","author":"BH Bochner","year":"2006","unstructured":"Bochner BH, Kattan MW, Vora KC (2006) Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 24(24):3967\u201372","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"2","key":"5837_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00345-017-2115-4","volume":"36","author":"A Mari","year":"2018","unstructured":"Mari A, Campi R, Tellini R, Gandaglia G, Albisinni S, Abufaraj M et al (2018) Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature. World Journal of Urology 36(2):157\u201370","journal-title":"World Journal of Urology"},{"issue":"2","key":"5837_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.eururo.2015.01.032","volume":"68","author":"LA Kluth","year":"2015","unstructured":"Kluth LA, Black PC, Bochner BH, Catto J, Lerner SP, Stenzl A et al (2015) Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature. European Urology 68(2):238\u201353","journal-title":"European Urology"},{"issue":"2","key":"5837_CR14","first-page":"93","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK et al (2017) The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA: A Cancer Journal for Clinicians 67(2):93\u20139","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"1","key":"5837_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.euo.2023.05.012","volume":"7","author":"E Crupi","year":"2024","unstructured":"Crupi E, de Padua TC, Marandino L, Raggi D, Dyrskj\u00f8t L, Spiess PE et al (2024) Circulating tumor DNA as a Predictive and Prognostic Biomarker in the Perioperative Treatment of Muscle-invasive Bladder Cancer: A Systematic Review. European Urology Oncology 7(1):44\u201352","journal-title":"European Urology Oncology"},{"issue":"11","key":"5837_CR16","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s11864-025-01355-z","volume":"26","author":"L Meng","year":"2025","unstructured":"Meng L, Khorasanchi A, Jain R (2025) Advancing Bladder Cancer Management: The Role of Neoadjuvant and Adjuvant Therapies and Biomarkers in Muscle Invasive Bladder Cancer. Current Treatment Options in Oncology 26(11):929\u201342","journal-title":"Current Treatment Options in Oncology"},{"key":"5837_CR17","doi-asserted-by":"crossref","unstructured":"Tan MP, Attard G, Huddart RA. Circulating Tumour DNA in Muscle-Invasive Bladder Cancer. International journal of molecular sciences. 2018;19(9).","DOI":"10.3390\/ijms19092568"},{"issue":"2","key":"5837_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/MOU.0000000000001136","volume":"34","author":"A Bouchalakis","year":"2024","unstructured":"Bouchalakis A, Somani BK, Lima E, Rassweiler-Seyfried MC, Mamoulakis C, Tokas T (2024) Navigation systems and 3D imaging in percutaneous nephrolithotripsy: improving outcomes and safety. Current Opinion in Urology 34(2):105\u20139","journal-title":"Current Opinion in Urology"},{"key":"5837_CR19","doi-asserted-by":"publisher","first-page":"110717","DOI":"10.1016\/j.ejrad.2023.110717","volume":"160","author":"AC Tsili","year":"2023","unstructured":"Tsili AC, Varkarakis I, Pasoglou V, Anagnostou N, Argyropoulou MI (2023) CT of the urinary tract revisited. European Journal of Radiology 160:110717","journal-title":"European Journal of Radiology"},{"issue":"4","key":"5837_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/03915603211022960","volume":"88","author":"A Panunzio","year":"2021","unstructured":"Panunzio A, Tafuri A, Princiotta A, Gentile I, Mazzucato G, Trabacchin N, et al. Omics in urology: An overview on concepts, current status and future perspectives. Urologia. 2021;88(4):270\u20139.","journal-title":"Urologia"},{"key":"5837_CR21","doi-asserted-by":"publisher","first-page":"1821743","DOI":"10.3389\/fimmu.2026.1821743","volume":"17","author":"Y Dong","year":"2026","unstructured":"Dong Y, Su Y (2026) Perspective on the integration of radiomics and spatial omics in the analysis of the tumor microenvironment of bladder cancer and prospects for precision diagnosis and treatment. Frontiers in Immunology 17:1821743","journal-title":"Frontiers in Immunology"},{"issue":"9","key":"5837_CR22","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.1002\/mp.17288","volume":"51","author":"S Xiong","year":"2024","unstructured":"Xiong S, Fu Z, Deng Z, Li S, Zhan X, Zheng F, et al. Machine learning-based CT radiomics enhances bladder cancer staging predictions: A comparative study of clinical, radiomics, and combined models. Medical physics. 2024;51(9):5965\u201377.","journal-title":"Medical physics"},{"key":"5837_CR23","doi-asserted-by":"crossref","unstructured":"Wo\u017anicki P, Laqua FC, Messmer K, Kunz WG, Stief C, N\u00f6renberg D, et al. Radiomics for the Prediction of Overall Survival in Patients with Bladder Cancer Prior to Radical Cystectomy. Cancers. 2022;14(18).","DOI":"10.3390\/cancers14184449"},{"issue":"1","key":"5837_CR24","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1186\/s12885-025-14279-6","volume":"25","author":"B Wang","year":"2025","unstructured":"Wang B, Gong Z, Su P, Zhen G, Zeng T, Ye Y (2025) Multi-machine learning model based on radiomics features to predict prognosis of muscle-invasive bladder cancer. BMC Cancer 25(1):1116","journal-title":"BMC Cancer"},{"issue":"6","key":"5837_CR25","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/jmri.26749","volume":"50","author":"X Xu","year":"2019","unstructured":"Xu X, Wang H, Du P, Zhang F, Li S, Zhang Z et al (2019) A predictive nomogram for individualized recurrence stratification of bladder cancer using multiparametric MRI and clinical risk factors. Journal of Magnetic Resonance Imaging: JMRI 50(6):1893\u2013904","journal-title":"Journal of Magnetic Resonance Imaging: JMRI"},{"key":"5837_CR26","doi-asserted-by":"publisher","first-page":"899897","DOI":"10.3389\/fonc.2022.899897","volume":"12","author":"J Qian","year":"2022","unstructured":"Qian J, Yang L, Hu S, Gu S, Ye J, Li Z et al (2022) Feasibility Study on Predicting Recurrence Risk of Bladder Cancer Based on Radiomics Features of Multiphase CT Images. Frontiers in Oncology 12:899897","journal-title":"Frontiers in Oncology"},{"key":"5837_CR27","doi-asserted-by":"publisher","first-page":"109219","DOI":"10.1016\/j.ejrad.2020.109219","volume":"131","author":"S Zhang","year":"2020","unstructured":"Zhang S, Song M, Zhao Y, Xu S, Sun Q, Zhai G et al (2020) Radiomics nomogram for preoperative prediction of progression-free survival using diffusion-weighted imaging in patients with muscle-invasive bladder cancer. European Journal of Radiology 131:109219","journal-title":"European Journal of Radiology"},{"key":"5837_CR28","doi-asserted-by":"publisher","first-page":"102352","DOI":"10.1016\/j.eclinm.2023.102352","volume":"66","author":"H Wang","year":"2023","unstructured":"Wang H, Zhang M, Miao J, Hou F, Chen Y, Huang Y, et al. Deep learning signature based on multiphase enhanced CT for bladder cancer recurrence prediction: a multi-center study. EClinicalMedicine. 2023;66:102352.","journal-title":"EClinicalMedicine"},{"issue":"5","key":"5837_CR29","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1097\/JS9.0000000000001194","volume":"110","author":"Z Wei","year":"2024","unstructured":"Wei Z, Xv Y, Liu H, Li Y, Yin S, Xie Y et al (2024) A CT-based deep learning model predicts overall survival in patients with muscle invasive bladder cancer after radical cystectomy: a multicenter retrospective cohort study. International Journal of Surgery (London, England) 110(5):2922\u201332","journal-title":"International Journal of Surgery (London, England)"},{"issue":"6","key":"5837_CR30","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.tig.2020.03.005","volume":"36","author":"CB Azodi","year":"2020","unstructured":"Azodi CB, Tang J, Shiu SH (2020) Opening the Black Box: Interpretable Machine Learning for Geneticists. Trends in Genetics: TIG 36(6):442\u201355","journal-title":"Trends in Genetics: TIG"},{"key":"5837_CR31","unstructured":"Lundberg SM, Lee S-IJAinips. A unified approach to interpreting model predictions. 2017;30."},{"issue":"1","key":"5837_CR32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1191\/0969733002ne486xx","volume":"9","author":"World Medical Association Declaration of Helsinki","year":"2002","unstructured":"World Medical Association Declaration of Helsinki (2002) Ethical principles for medical research involving human subjects. Nursing Ethics 9(1):105\u20139","journal-title":"Nursing Ethics"},{"key":"5837_CR33","first-page":"90","volume":"380","author":"A Braillon","year":"2023","unstructured":"Braillon A, Naudet F. STROBE and pre-registration of observational studies. BMJ (Clinical research ed). 2023;380:90.","journal-title":"BMJ (Clinical research ed)"},{"issue":"3","key":"5837_CR34","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.eururo.2006.03.027","volume":"50","author":"AO Yurakh","year":"2006","unstructured":"Yurakh AO, Ramos D, Calabuig-Fari\u00f1as S, L\u00f3pez-Guerrero JA, Rubio J, Solsona E, et al. Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder. Eur Urol. 2006;50(3):506\u201315; discussion 15.","journal-title":"Eur Urol"},{"issue":"22","key":"5837_CR35","first-page":"3206","volume":"27","author":"MS Schr\u00f6der","year":"2011","unstructured":"Schr\u00f6der MS, Culhane AC, Quackenbush J, Haibe-Kains B. survcomp: an R\/Bioconductor package for performance assessment and comparison of survival models. Bioinformatics (Oxford, England). 2011;27(22):3206\u20138.","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"2","key":"5837_CR36","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jamcollsurg.2013.02.027","volume":"217","author":"ME Cohen","year":"2013","unstructured":"Cohen ME, Ko CY, Bilimoria KY, Zhou L, Huffman K, Wang X, et al. Optimizing ACS NSQIP modeling for evaluation of surgical quality and risk: patient risk adjustment, procedure mix adjustment, shrinkage adjustment, and surgical focus. Journal of the American College of Surgeons. 2013;217(2):336\u2009\u2013\u200946.e1.","journal-title":"Journal of the American College of Surgeons"},{"issue":"1","key":"5837_CR37","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41392-024-01932-y","volume":"9","author":"Z Chen","year":"2024","unstructured":"Chen Z, Chen Y, Sun Y, Tang L, Zhang L, Hu Y et al (2024) Predicting gastric cancer response to anti-HER2 therapy or anti-HER2 combined immunotherapy based on multi-modal data. Signal Transduction and Targeted Therapy 9(1):222","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"8","key":"5837_CR38","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos A, Schrag D, Raj GV, Panageas KS (2008) How to build and interpret a nomogram for cancer prognosis. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 26(8):1364\u201370","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"14","key":"5837_CR39","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/jama.2017.12126","volume":"318","author":"AC Alba","year":"2017","unstructured":"Alba AC, Agoritsas T, Walsh M, Hanna S, Iorio A, Devereaux PJ, et al. Discrimination and Calibration of Clinical Prediction Models: Users\u2019 Guides to the Medical Literature. Jama. 2017;318(14):1377\u201384.","journal-title":"Jama"},{"issue":"1","key":"5837_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13244-023-01445-2","volume":"14","author":"C Li","year":"2023","unstructured":"Li C, He Z, Lv F, Liu Y, Hu Y, Zhang J et al (2023) An interpretable MRI-based radiomics model predicting the prognosis of high-intensity focused ultrasound ablation of uterine fibroids. Insights into Imaging 14(1):129","journal-title":"Insights into Imaging"},{"issue":"1","key":"5837_CR41","doi-asserted-by":"publisher","first-page":"7040","DOI":"10.1038\/s41467-024-51260-6","volume":"15","author":"Y Wei","year":"2024","unstructured":"Wei Y, Yang M, Zhang M, Gao F, Zhang N, Hu F et al (2024) Focal liver lesion diagnosis with deep learning and multistage CT imaging. Nature Communications 15(1):7040","journal-title":"Nature Communications"},{"key":"5837_CR42","doi-asserted-by":"crossref","unstructured":"Wang R, Shi XS, Pang ST, Chen YD, Zhu XF, Wang WT, et al. Cross-attention guided loss-based deep dual-branch fusion network for liver tumor classification. Information Fusion. 2025;114.","DOI":"10.1016\/j.inffus.2024.102713"},{"issue":"5","key":"5837_CR43","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"8036","key":"5837_CR44","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41586-024-08087-4","volume":"634","author":"CK Mo","year":"2024","unstructured":"Mo CK, Liu J, Chen S, Storrs E, Targino da Costa ALN, Houston A, et al. Tumour evolution and microenvironment interactions in 2D and 3D space. Nature. 2024;634(8036):1178\u201386.","journal-title":"Nature"},{"key":"5837_CR45","doi-asserted-by":"publisher","first-page":"628577","DOI":"10.3389\/fonc.2021.628577","volume":"11","author":"H Yu","year":"2021","unstructured":"Yu H, Meng X, Chen H, Liu J, Gao W, Du L et al (2021) Predicting the Level of Tumor-Infiltrating Lymphocytes in Patients With Breast Cancer: Usefulness of Mammographic Radiomics Features. Frontiers in Oncology 11:628577","journal-title":"Frontiers in Oncology"},{"issue":"9","key":"5837_CR46","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1158\/1078-0432.CCR-10-2770","volume":"17","author":"JB Shah","year":"2011","unstructured":"Shah JB, McConkey DJ, Dinney CP (2011) New strategies in muscle-invasive bladder cancer: on the road to personalized medicine. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(9):2608\u201312","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"key":"5837_CR47","doi-asserted-by":"crossref","unstructured":"St-Laurent MP, Nikkola J, Tomiyama E, Black PC. Advances in the management of localized bladder cancers. Nature reviews Clinical oncology. 2026.","DOI":"10.1038\/s41571-025-01104-z"},{"issue":"4","key":"5837_CR48","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1159\/000474499","volume":"31","author":"JA Witjes","year":"1997","unstructured":"Witjes JA, Wullink M, Oosterhof GO, de Mulder P (1997) Toxicity and results of MVAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in advanced urothelial carcinoma. European Urology 31(4):414\u20139","journal-title":"European Urology"},{"issue":"6","key":"5837_CR49","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.euo.2021.04.004","volume":"5","author":"MC Mir","year":"2022","unstructured":"Mir MC, Campi R, Loriot Y, Puente J, Giannarini G, Necchi A et al (2022) Adjuvant Systemic Therapy for High-risk Muscle-invasive Bladder Cancer After Radical Cystectomy: Current Options and Future Opportunities. European Urology Oncology 5(6):726\u201331","journal-title":"European Urology Oncology"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05837-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-026-05837-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05837-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:02:21Z","timestamp":1792677741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-026-05837-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":49,"alternative-id":["5837"],"URL":"https:\/\/doi.org\/10.1007\/s00261-026-05837-y","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"27 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}